BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2010
View Archived Issues
Basilea Pharmaceutica claims new antibacterial agents
Read More
Avexa and Shanghai TargetDrug describe new NS5B inhibitors
Read More
Orchid Chemicals & Pharmaceuticals discovers new PDE4 inhibitors
Read More
Hybrigenics presents new USP7 inhibitors
Read More
German scientists disclose new antiarrhythmic agents
Read More
Algeta begins phase I/IIa trial of Alpharadin/docetaxel combination in CRPC
Read More
Herceptin approved in Canada for HER2-positive stomach cancer
Read More
Epitherix identifies novel chemical scaffolds targeting Wnt pathway
Read More
Karo Bio to present phase III development plan for eprotirome in high-risk HeFH
Read More
Carbamazepine enhances autophagy and decreases hepatic fibrosis in vivo
Read More
Serum uric acid level is a biomarker for new-onset diabetes
Read More
Scientists select new H3 receptor antagonists as clinical candidates for sleep disorders
Read More
Scientists identify potential susceptibility loci for endometriosis
Read More
Midbrain [18F]-fallypride PET can reveal impulsivity in individuals
Read More
Dr. Reddy's launches biosimilar darbepoetin alfa for anemia in India
Read More
Crucell, IAVI and BIDMC to conduct phase I AdVac-based AIDS vaccine trial
Read More
D-Pharm reports results from DP-b99 cardiac safety study
Read More
FDA approves NovoSeven RT 8-mg vial for hemophilia A and B
Read More
FDA clears Curemark's IND for CM-4612 in ADHD
Read More
Healthpoint advances Collagenase Santyl for diabetes-associated foot ulcers
Read More
Pathway Therapeutics raises funds for PI3K inhibitor development
Read More
Trigemina reports phase IIa data on TI-001 in chronic daily headache
Read More
ACT and Brown Cancer Center collaborate to identify cancer therapeutics
Read More
Biotest reports final data from phase IIa trial of BT-061 in RA
Read More
Biotest updates development program for BT-062 in multiple myeloma
Read More